Ther­mo Fish­er ex­pects last­ing ben­e­fits to bill tar­get­ing Chi­nese ser­vice providers

Ther­mo Fish­er said it will be a “long-term ben­e­fi­cia­ry” of bio­phar­ma cus­tomers lo­cal­iz­ing their sup­ply chains, giv­en most of its net­work is based in the US and Eu­rope.

Clients are think­ing more se­ri­ous­ly about where their man­u­fac­tur­ing part­ners are based in light of po­ten­tial dis­rup­tions such as the Biose­cure Act, Ther­mo’s CEO Marc Casper said dur­ing its first-quar­ter earn­ings call. “Cus­tomers are turn­ing to us more than ever … It’s our job to help our cus­tomers through shift­ing land­scapes,” he added.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER